Parisi Alessio, Furutani Keith M, Beltran Chris J
Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida, USA.
Phys Imaging Radiat Oncol. 2024 Feb 29;29:100564. doi: 10.1016/j.phro.2024.100564. eCollection 2024 Jan.
The effort to translate clinical findings across institutions employing different relative biological effectiveness (RBE) models of ion radiotherapy has rapidly grown in recent years. Nevertheless, even for a chosen RBE model, different implementations exist. These approaches might consider or disregard the dose-dependence of the RBE and the radial variation of the radiation quality around the beam axis. This study investigated the theoretical impact of disregarding these effects during the RBE calculations.
Microdosimetric simulations were carried out using the Monte Carlo code PHITS along the spread out Bragg peaks of H, He, C, O, and Ne ions in a water phantom. The RBE was computed using different implementations of the Mayo Clinic Florida microdosimetric kinetic model (MCF MKM) and the modified MKM, considering or not the radial variation of the radiation quality in the penumbra of the ion beams and the dose-dependence of the RBE.
For an OAR located 5 mm laterally from the target volume, disregarding the radial variation of the radiation quality or the dose-dependence of the RBE could result in an overestimation of the RBE-weighted dose up to a factor of ∼ 3.5 or ∼ 1.7, respectively.
The RBE-weighted dose to OARs close to the tumor volume was substantially impacted by the approach employed for the RBE calculations, even when using the same RBE model and cell line. Therefore, care should be taken in considering these differences while translating clinical findings between institutions with dissimilar approaches.
近年来,在采用不同离子放疗相对生物效应(RBE)模型的各机构间转化临床研究结果的工作迅速增加。然而,即使对于选定的RBE模型,也存在不同的实现方式。这些方法可能会考虑或忽略RBE的剂量依赖性以及束轴周围辐射质量的径向变化。本研究调查了在RBE计算过程中忽略这些效应的理论影响。
使用蒙特卡罗代码PHITS在水模体中沿H、He、C、O和Ne离子的扩展布拉格峰进行微剂量模拟。使用佛罗里达梅奥诊所微剂量动力学模型(MCF MKM)和改进的MKM的不同实现方式计算RBE,同时考虑或不考虑离子束半影区辐射质量的径向变化以及RBE的剂量依赖性。
对于位于靶区横向5 mm处的危及器官,忽略辐射质量的径向变化或RBE的剂量依赖性,可能分别导致RBE加权剂量高估约3.5倍或1.7倍。
即使使用相同的RBE模型和细胞系,靠近肿瘤体积的危及器官的RBE加权剂量也会受到RBE计算方法的显著影响。因此,在不同方法的机构间转化临床研究结果时,应注意考虑这些差异。